- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BI 655066 (low s.c. dose)
Total 1942 results
-
AbbVieBoehringer IngelheimCompletedPsoriasisUnited States, Germany, United Kingdom
-
Boehringer IngelheimCompletedLupus NephritisSpain, United Kingdom, United States, Canada, Thailand, Germany, Italy, Japan, Serbia, Australia, Korea, Republic of, Mexico, Malaysia, Philippines, Poland, Portugal, Greece, Hong Kong, Czechia, France
-
Boehringer IngelheimCompletedHepatitis C, ChronicFrance, Germany, Switzerland
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
AbbVieNo longer availableCrohn's Disease | Ulcerative Colitis (UC)
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany
-
Boehringer IngelheimCompleted
-
AbbVieCompletedPsoriasisUnited States, Australia, Austria, Belgium, Canada, Czechia, Finland, France, Germany, Japan, Korea, Republic of, Mexico, Poland, Portugal, Spain, Sweden, Taiwan
-
AbbVieCompletedA Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic DermatitisDermatitisUnited States, Australia, Canada, Japan, Puerto Rico
-
AbbVieCompleted
-
AbbVieBoehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHealthyKorea, Republic of
-
Boehringer IngelheimCompleted
-
AbbVieBoehringer IngelheimCompleted
-
AbbVieActive, not recruitingPsoriatic Arthritis (PsA)United States, Argentina, Australia, Belgium, Brazil, Canada, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Singapore, South Africa, Spain, Sweden, United...
-
AbbVieCompletedPsoriasisUnited States, Canada, France, Germany, Italy, Netherlands, Poland, Spain, United Kingdom
-
Boehringer IngelheimCompleted
-
AbbVieCompletedRisankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation (IMMPRESS)PsoriasisRussian Federation
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Croatia, Czech Republic, Denmark, Estonia, France, Georgia, Greece, Hong Kong, Hungary, India, Indonesia, Israel, Italy, Japan, Korea, Republic of, Malaysia and more
-
Boehringer IngelheimCompletedHealthy | Arthritis, RheumatoidGermany, Netherlands, New Zealand, Poland, Spain, Czechia
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Denmark, Estonia, Hungary, Italy, Lebanon, Malaysia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Spain, Sweden, Taiwan
-
AbbVieBoehringer IngelheimCompletedAsthmaUnited States, Korea, Republic of, Belgium, Taiwan, Canada, Germany, United Kingdom, France, Netherlands, Poland
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminatedPurpura, Thrombocytopenic, IdiopathicUnited States
-
AbbVieCompleted
-
AbbVieActive, not recruitingPsoriatic ArthritisUnited States, Argentina, Australia, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile, Croatia, Czechia, Denmark, Estonia, Finland, Germany, Greece, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico and more
-
Boehringer IngelheimCompletedLupus NephritisUnited Kingdom, Thailand, Germany, Japan, United States, Australia, Korea, Republic of, Hong Kong, Poland, Greece, Mexico, Czechia, Canada, Malaysia, Philippines, Portugal
-
Hebrew University of JerusalemaMoon fundCompletedDepressive Symptoms | Mood DisturbanceIsrael
-
Boehringer IngelheimCompletedHealthyJapan, Korea, Republic of
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany
-
Boehringer IngelheimCompletedSchizophreniaSpain, Korea, Republic of, United Kingdom, Taiwan, United States, Austria, Italy, Germany, Poland, Japan, Canada
-
AbbVieBoehringer IngelheimCompletedCrohn DiseaseUnited States, Belgium, Canada, Germany, Korea, Republic of, Netherlands, Poland, Spain, United Kingdom
-
AbbVieCompletedUlcerative Colitis (UC)United States, Argentina, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Egypt, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Nether... and more
-
AbbVieBoehringer IngelheimCompleted
-
Boehringer IngelheimCompletedAlzheimer DiseaseSpain, United Kingdom, Italy, United States, Canada, Germany, Greece, Austria, Norway, France, Japan, Hungary, Poland, Finland
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Denmark, France, Ireland, Korea, Republic of, Portugal, United Kingdom
-
Boehringer IngelheimCompletedHepatitis C, ChronicUnited States, Germany, Spain, United Kingdom
-
Prometheus Biosciences, Inc., a subsidiary of Merck...Altasciences Company Inc.Completed
-
AbbVieCompletedCrohn's DiseaseUnited States, Argentina, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czechia, Estonia, Germany, Greece, Hong Kong, Ireland, Israel, Italy, Japan, Korea, Republic... and more
-
AbbVieCompletedCrohn's DiseaseUnited States, Argentina, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Egypt, Estonia, France, Germany, Greece, Ireland, Israel, Italy, Korea, Republic... and more
-
Boehringer IngelheimCompleted